ClinicalTrials.gov
public full text
Public Domain
VITROS Immunodiagnostic Products NT-proBNP II
Amino Terminal pro-Brain Natriuretic Peptide (NTproBNP) is secreted in conditions of cardiac wall stress. NTproBNP levels are used in addition to clinical assessment to diagnose heart failure (HF). The purpose of this clinical study is to collect data to substantiate the use of the VITROS NT-proBNP II assay.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Cut-off Value Study of N-terminal Brain Natriuretic Peptide （Chemiluminescence Method）#909778
- Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone#854794
- The Study of NT-proBNP Combined With HS-cTnT in Evaluating the Prognosis of Sepsis#1047244
- Point of Care NT-proBNP Testing for Suspected New Heart Failure Acute Care#807467
- Proteomics of Brain Trauma-associated Elevated Intracranial Pressure (ICP)#913433
Record · ID 844586
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive